SCHEMBL29123079

SCHEMBL29123079

C=CCCNC(=O)c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.62
MAOB P27338 2/20 0.62
NFKB1 P19838 2/20 0.62
TSHR P16473 1/20 0.62
KMT2A Q03164 2/20 0.60
MEN1 O00255 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60
NPC1 O15118 4/20 0.54
RAB9A P51151 3/20 0.54
MAPT P10636 2/20 0.54
GAA P10253 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54
GFER P55789 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 1/20 0.52
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9584535 0.83 CYP1A2 (0.78) CYP1A2MAOBNFKB1TSHRKMT2A
SCHEMBL31414540 0.83 SMN1; SMN2 (0.54) NFKB1TSHRKMT2AMEN1NPC1
SCHEMBL24227389 0.82 RAB9A (0.69) CYP1A2MAOBNFKB1TSHRKMT2A
SCHEMBL8007465 0.82 LMNA (0.60) KMT2ANPC1RAB9AGAASMN1; SMN2
SCHEMBL29122556 0.80 EPHX2 (0.50) ALDH1A1MCHR1CD274
SCHEMBL4347910 0.79 SMN1; SMN2 (0.44) CYP1A2MAOBNFKB1TSHRKMT2A
SCHEMBL29122533 0.79 PKM (0.72) NFKB1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL11476769 0.78 CYP1A2 (0.70) CYP1A2MAOBNFKB1TSHRKMT2A
SCHEMBL9491749 0.78 HDAC3 (0.76) CYP1A2MAOBNFKB1TSHRKMT2A
SCHEMBL9585652 0.78 CYP1A2 (0.70) CYP1A2MAOBNFKB1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117185952-A Alpha-arylamine compound and preparation method and application thereof 天津师范大学 2023-12-08 CN disclosed